LMO2, also known as LIM-Only transcription factor 2, RBTN2, or TTG2, is an oncoprotein that is expressed in normal germinal center B-cells, as well as bone marrow hematopoietic precursors and endothelial cells. LMO2 plays a role in angiogenesis and hematopoesis, and its expression has been detected in erythroid and myeloid precursors, megakaryocytes, and also in lymphoblastic and acute myeloid leukemias. LMO2 protein expression has been noted in diffuse large B-cell lymphoma, the most common adult non-Hodgkin lymphoma, as well as follicular lymphoma, a neoplasm derived from germinal center B-cells that accounts for a number of cases of non-Hodgkin lymphomas.

SKU: N/A Category:
Image Variation SKU Price Quantity Add To Cart
LMO2-IHC615-Tonsil 0.1ml IHC615-100 486.00
Add to cart
LMO2-IHC615-Tonsil 1ml IHC615-1 2,548.00
Add to cart
LMO2-IHC615-Tonsil Positive Control 3 slides IHC615-PC 770.00
Add to cart


CE-IVD registered and supplied as a concentrate.   


Clone IHC615 IHC615
Source Mouse Monoclonal
Positive Control Tonsil, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma
Dilution Range 1:100 – 1:200


  1. Fouad-Younes S, et al. Am J Surg Pathol. 2010; 34:1266-76.
  2. Natkunam Y, et al. Blood. 2007; 109:1636-42.

Additional information


0.1ml, 1ml, Positive Control 3 slides


Instructions for Use

Safety Data Sheet

Price Quote